RetinalGenix Technologies (RTGN) Debt Ratio (2021 - 2026)
RetinalGenix Technologies (RTGN) reported Debt Ratio of 8.44 for Q1 2026, up 105.53% on a YoY basis from 4.11 in Q1 2025, and up 81.23% sequentially from 4.66 in Q4 2025.
RetinalGenix Technologies (RTGN) Debt Ratio (2021 - 2026) Analysis & Trends
RetinalGenix Technologies (RTGN) has 6 years of Debt Ratio data on file, last reported at 8.44 in Q1 2026.
- For the quarter ending Q1 2026, Debt Ratio rose 105.53% year-over-year to 8.44; the trailing twelve-month figure through Mar 2026 stood at 8.44 (up 105.53% YoY), and the FY2025 full-year result was 4.66, up 42.07% from the prior year.
- Debt Ratio advanced to 8.44 in Q1 2026, from 4.66 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 2703.7 in Q2 2022 to a low of 0.55 in Q3 2024.
- A 5-year average of 216.16 and a median of 7.0 in 2025 frame the typical range for Debt Ratio.
- Across the five-year window, Debt Ratio surged 2158.9% in 2022 and plunged 99.75% in 2024, its largest moves.
- Tracing RTGN's Debt Ratio over 5 years: stood at 333.33 in 2022, then slipped by 5.77% to 314.1 in 2023, then plunged by 98.96% to 3.28 in 2024, then surged by 42.07% to 4.66 in 2025, then jumped by 81.23% to 8.44 in 2026.
- Business Quant data shows RTGN's Debt Ratio at 8.44 in Q1 2026, 4.66 in Q4 2025, and 7.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.30 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.04 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.30 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.27 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 0.30 |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | 8.44 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.44 |
| Dec 31, 2025 | 4.66 |
| Sep 30, 2025 | 7.00 |
| Jun 30, 2025 | 5.84 |
| Mar 31, 2025 | 4.11 |
| Dec 31, 2024 | 3.28 |
| Sep 30, 2024 | 0.55 |
| Jun 30, 2024 | 0.56 |
| Mar 31, 2024 | 0.97 |
| Dec 31, 2023 | 314.10 |
| Sep 30, 2023 | 217.78 |
| Jun 30, 2023 | 23.12 |
| Mar 31, 2023 | 6.36 |
| Dec 31, 2022 | 333.33 |
| Sep 30, 2022 | 12.26 |
| Jun 30, 2022 | 2,703.70 |
| Mar 31, 2022 | 28.57 |
| Dec 31, 2021 | 14.76 |
| Sep 30, 2021 | 4.49 |